Cases & Deals

  • Home
  • Practices
  • PDL BioPharma goes head to head against UCB Pharma in patent interference involving reshaped humanized immunoglobulins

Share

PDL BioPharma goes head to head against UCB Pharma in patent interference involving reshaped humanized immunoglobulins

December 2009

Client(s) PDL BioPharma, Inc.

Jones Day represented PDL BioPharma, Inc. in patent interference against UCB Pharma S.A. involving "reshaped" humanized immunoglobulins.

Adair (UCB) v. Queen (PDL BioPharma), Interference No. 105,688

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.